NEW YORK (Reuters Health) – For many patients with HIV receiving highly active antiretroviral therapy (HAART), routine bone mineral density (BMD) assessment may not be necessary because BMD…
NEW YORK (Reuters Health) – In HIV-1-uninfected newborns of HIV-infected mothers, treatment with the protease inhibitor lopinavir-ritonavir may lead to adrenal dysfunction, including life-threatening adrenal insufficiency in premature…
NEW YORK (Reuters Health) – Besides preventing HIV-1 mother-to-child transmission (PMTCT), triple antiretroviral therapy during pregnancy improves pregnancy outcomes, according to findings published in the June 6th online…
NEW YORK (Reuters Health) – The dilemma of when to start antiretroviral therapy (ART) in patients presenting with tuberculous meningitis associated with HIV infection has been answered by…
NEW YORK (Reuters Health) – A vaccine against Haemophilus influenzae and Neisseria meningitidis given to infants during their first year has an acceptable safety profile and induces protective…
NEW YORK (Reuters Health) – The longitudinal decline in lung function seen in patients with common variable immunodeficiency and X-linked agammaglobulinemia is related to immunoglobulin replacement level and…
NEW YORK (Reuters Health) – The combination of niacin and fenofibrate, along with diet and exercise, markedly improves the lipid profile of HIV patients on antiretroviral therapy (ART),…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses ICAMiA’s AIDS Training Program. For more information on ICAMiA’s important work in Africa, please read…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses the work that the Israel Consortium on AIDS Medicine in Africa (ICAMiA) collaborates on with…
NEW YORK (Reuters Health) – Insulin resistance substantially curbs the chances of a sustained viral response following standard treatment for chronic hepatitis C virus (HCV) infection, according to…